Articles Accepted

DIALKYL ISOMERS OF BENZENESULFONAMIDPHENYLPYRIMIDINE-4(1H)-ONE: SYNTHESIS, STRUCTURE, AND PHARMACOLOGICAL STUDIES
by Dr. Denis, 06 Sep 2023
Co-Author(s): Denis Anenko,Ivan Kodonidi,Sergey Kirik,Tamara Glizhova,Narzullo Saidov

Two isomeric benzenesulfonamidphenylpyrimidin-4(1H)-ones have been obtained by cyclocondensation of N-acyl-β-ketoamides with sulfanilamide. In positions 2 and 6, the synthesized phenylpyrimidin-4(1H)-ones contained methyl and ethyl as substituents in the first case 4-(6-ethyl-2-methyl-4-oxo-5-phenyl-pyrimidin-1-yl)-benzsulfamide (IIa), and ethyl and methyl – in the second one 4-(6-methyl-2-ethyl-4-oxo-5-phenyl-pyrimidin-1-yl)-benzsulfamide (IIb), respectively. The crystal structures of the compounds have been determined by an X-ray powder diffraction. It has been established that the positions of substituents significantly affect the conformation of molecules. In molecule IIa, the phenyl ring is rotated to the pyrimidine one by 84°; in IIb, the both rings lie in the same plane. Due to different conformations, the packing of molecules in the crystal lattice changes significantly. Pharmacological properties of isomeric pyrimidinones have been studied in relation to the anti-inflammatory and cerebroprotective activity in chronic traumatic encephalopathy. A comparative analysis of the drug similarity has been carried out. Screening of anti-inflammatory and cerebroprotective activities has shown that compound IIa surpassed its structural isomer in the pharmacological action, which was interpreted as a greater elasticity result of molecule IIa compared to IIb due to the less extended π-system.

Current Issue
December 2023
Quick Contact